logo

CNS

Cohen & Steers·NYSE
--
--(--)
--
--(--)
5.89 / 10
Netural

Fundamental analysis rates CNS at 5.9/10. Strengths include high inventory turnover (103.9), strong fixed‑asset turnover (9306), solid current ratio (3.94) and gross margin (41.8%). Weaknesses are a negative Asset‑MV factor and ROA (‑10.8%), and zero EPS growth, yielding a mixed rating.

Fundamental(5.89)SentimentTechnical

Analysis Checks(9/10)

Inventory turnover ratio
Value103.94
Score2/3
Weight9.50%
1M Return1.58%
Gross profit margin (%)
Value41.83
Score2/3
Weight9.71%
1M Return1.58%
Quick ratio
Value2.28
Score2/3
Weight9.49%
1M Return1.58%
Rate of return on total assets (%)
Value-10.79
Score2/3
Weight9.61%
1M Return1.61%
Fixed assets turnover ratio
Value9306.28
Score3/3
Weight17.12%
1M Return2.82%
Annualized return on total assets (%)
Value-10.79
Score2/3
Weight9.61%
1M Return1.61%
Diluted earnings per share (YoY growth rate %)
Value0.00
Score2/3
Weight17.21%
1M Return2.92%
Asset-MV
Value-0.55
Score0/3
Weight-6.86%
1M Return-1.25%
Current assets / Total assets (%)
Value47.20
Score3/3
Weight13.50%
1M Return2.34%
Current ratio
Value3.94
Score3/3
Weight11.10%
1M Return1.91%
Is CNS fundamentally strong?
  • CNS scores 5.89/10 on fundamentals and holds a Fair valuation at present. Backed by its 25.35% ROE, 28.30% net margin, 20.40 P/E ratio, 4.93 P/B ratio, and -0.33% earnings growth, these metrics solidify its Netural investment rating.